The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects

• Feng Zhang,

  Affiliations Department of Medicine, Hematology/Oncology, University of Münster, Münster, Germany, Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an, China

  ⨯
• Nicole Bäumer,

  Affiliation Department of Medicine, Hematology/Oncology, University of Münster, Münster, Germany

  ⨯
• Miriam Rode,

  Affiliation Department of Medicine, Hematology/Oncology, University of Münster, Münster, Germany

  ⨯
• Ping Ji,

  Affiliations Department of Medicine, Hematology/Oncology, University of Münster, Münster, Germany, Department of Pathology, MD Anderson Cancer Center, Texas University, Houston, Texas, United States of America

  ⨯
• Tao Zhang,

  Affiliation Department of Thoracic Surgery, Tangdu Hospital, the Fourth Military Medical University, Xi'an, China

  ⨯
• Wolfgang E. Berdel,

  Affiliation Department of Medicine, Hematology/Oncology, University of Münster, Münster, Germany

  ⨯
• Carsten Müller-Tidow

  * E-mail: muellerc@ukmuenster.de

  Affiliation Department of Medicine, Hematology/Oncology, University of Münster, Münster, Germany

  ⨯